Printer Friendly Our Approach
The Arcas Group is launching an innovative and exciting approach to improving your understanding of oncology treatment on a global basis, addressing several key challenges.
- Oncology treatment is highly personalized and differs from country to country. It is difficult to understand treatment trends and key influences on treatment decisions;
- Gaining ThoughtLeader insight and analysis that is independent of direct relationships with commercial interests;
- Heightened scrutiny of relationships between thoughtleaders and parties with commercial interests;
- Comprehensive clinician intelligence accessible from a single information source that accommodates your rules that govern reporting and analysis.
MDOUTLOOK™ provides a strategic approach to medical intelligence by combining comprehensive clinician treatment data with exclusive directional analysis, provided by global ThoughtLeaders.
MDOUTLOOK™ offers subscribers comprehensive historical, real-time and projectable data, combined with exclusive analysis, that reveals the clinician's mindset and critical information / education gaps in order to provide directional insight that allows you to align, allocate and deploy resources in a more efficient and effective manner.
- Developed and guided by prominent global / national ThoughtLeaders
- Representing multi-disciplinary perspectives; clinical and academic points of view
- Ensuring scientific and clinical rigueur - market expertise
- Driven by assembled clinician panels who treat the target tumor types
- Providing detailed reports on their treatment regimen
- Providing rationale and perspective for their treatment decisions
- Augmented by global clinician data sourcing
- Delivering information and intelligence from a statistically significant % of oncology clinicians
MDOUTLOOK™ offers subscribers a secure web portal featuring integrated data management tools that drive user friendly organized information screens, standard and custom reports and charts. Subscribers of MDOUTLOOK™ also gain exclusive access to global ThoughtLeaders for analysis of clinician treatment trends as they specifically relate to your product(s) and present their insight via dedicated live forums.
 |
Exclusive ThoughtLeader Analysis and Access |
|
Extensive Physician Reach |
|
Comprehensive Intelligence Repository |
|
Multiple Information Sources |
Our Experience
Our team has a strong track record in strategic and management consultancy. A list of sample projects can be found below as well as a selection of healthcare and non-healthcare clients previously advised. Should you want to receive more detailed information on our past experience or client references, please contact us here.Sample projects:
- Market assessment (cervical cancer vaccine, cholesterol-lowering agent, anti-diabetic compound, new oncology therapy, growth strategies for medical services company);
- Product and service enhancement (new indication for dermatology product, launch of consumer products, medical research services);
- Commercial due diligence (French pharmaceutical company, biotech company in UK, dermatology portfolio of US-based pharmaceutical company);
- Licensing (anti-inflammatory product, psychiatry drugs, optimizing in-licensing process);
- Organizational issues (creating biotech spin-off, pharmaceutical distribution, setting up account management, process enhancement in IT organization).
Selection of healthcare clients previously advised:
Allergan
AstraZeneca
Bioglan
Boehringer Ingelheim
Cambridge Antibody Technology
Cephalon
CSL
Chugai Rhone Poulenc Rorer
Dimethaid
Eli Lilly
Gilead
InterMune
Novo Nordisk
Pfizer
Pharmacia
Pharmagene
Schering Plough
SkyePharma
Selection of non-healthcare clients previously advised:
ABN AMRO
Frikifrisch, GmBH
The Greenery
ING Bank
Koninklijke Numico
Koninklijke De Ruijter
Ohra
KPN
Origin
Sara Lee Douwe Egberts
SG Cowen
Unilever
